Medicine and Dentistry
Alzheimer's Disease
100%
Biological Marker
50%
Carbon 11
50%
Pathology
50%
Neuroinflammation
44%
Episodic Memory
44%
Mild Cognitive Impairment
41%
Mitochondrial Membrane Transport Protein
39%
Amyloid Beta
33%
Measurement
33%
Magnetic Resonance Imaging
29%
Aging
26%
Development
22%
Glia
22%
Volunteer
22%
Association
22%
Blood
22%
Genotype
22%
Senescence
17%
Positron Emission Tomography
16%
Radioactive Tracer
16%
Structural Magnetic Resonance Imaging
16%
Marker
14%
Age
14%
Memory Disorder
14%
Laboratory
11%
Serositis
11%
Drug
11%
Follow up
11%
Analysis
11%
Tenidap
11%
Chemotherapeutic Agent
11%
Evaluation Study
11%
Diseases
11%
Cognition
11%
Informed Consent
11%
Diagnosis
11%
Cerebrospinal Fluid
11%
Beta1 Integrin
11%
Multimodal Imaging
11%
Synaptic Vesicle
11%
N Sec Butyl 1 (2 Chlorophenyl) N Methyl 3 Isoquinolinecarboxamide C 11
11%
Genetic Risk
11%
Gold
11%
Blood Sampling
11%
Standardized Uptake Value
11%
Disease Process
11%
Cerebrovascular Disease
8%
Cognitive Defect
8%
Patient with Alzheimer's Disease
8%
Neuroscience
Episodic Memory
89%
Mild Cognitive Impairment
80%
Magnetic Resonance Imaging
40%
Translocator Protein
39%
Beta Amyloid
37%
Free Recall
28%
Amyloid
24%
Memory Disorder
18%
Magnetic Resonance Imaging of Brain
17%
Occipital Lobe
17%
Cognitive Effect
17%
Synaptic Vesicle
11%
Magnetic Resonance Imaging
11%
Beta1 Integrin
11%
In Vivo
11%
Cognitive Disorders
8%
Verbal Memory
8%
Left Handedness
5%
Positron Emission Tomography
5%
Radioligand
5%
Nursing and Health Professions
Alzheimer Disease
40%
Carbon 11
40%
Carrier Protein
39%
Amyloid
28%
Nervous System Inflammation
22%
Standardized Uptake Value Ratio
20%
Standardized Uptake Value
11%
Female
11%
Memory Disorder
9%
Control
8%
Positron Emission Tomography
5%
Biological Marker
5%
Acetic Acid Derivative
5%
Marker
5%
Radioligand
5%
Confidence Interval
5%
Tracer
5%
Mild Cognitive Impairment
5%
Volume
5%
Indicator
5%
Electric Potential
5%
Imaging
5%
